Hibernia Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Hibernia Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	-$437	–	183
2023 Q3	$437	Buy	+1	New	+$499	﹤0.01%	323

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hibernia Wealth Partners's IDXX Position: Q4 2023 in Review

Hibernia Wealth Partners sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 1 share — an estimated $437 sold.

Hibernia Wealth Partners first reported a position in IDXX in Q3 2023 and held it in 1 quarter. The position peaked at $437 in Q3 2023. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

Hibernia Wealth Partners reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
Hibernia Wealth Partners sold 1 Idexx Laboratories share in Q4 2023, an estimated $437.
Hibernia Wealth Partners first reported a position in Idexx Laboratories in Q3 2023 and held it in 1 quarter.
Hibernia Wealth Partners's Idexx Laboratories position peaked at $437 in Q3 2023.
1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Hibernia Wealth Partners's 13F filing for Q4 2023, filed 19 Jan 2024.